Magnitude of functional CD8+ T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma

Journal of Virology

Volumn 76, Issue 5, 2002, Pages 2298-2305

  Edwards, Bradley H ^a   Bansal, Anju ^a   Sabbaj, Steffanie ^a   Bakari, Janna ^a   Mulligan, Mark J ^a   Goepfert, Paul A ^a  

^a Center for Palliative Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 160; INTEGRASE; NEF PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; BACULOVIRUS; BLOOD SAMPLING; CELLULAR IMMUNITY; CHRONIC DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD;

EID: 0036171258     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.76.5.2298-2305.2002     Document Type: Article

References (54)

1. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
2. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: Results of the women's interagency HIV study
3. Reduction of simian-human immunodeficiency virus 89.6p viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination
4. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
5. + T-cell responses: Relationship to viral load in untreated HIV infection
6. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
8. Alopecia associated with indinavir therapy
9. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
10. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
11. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
12. + T cells in peripheral blood after initiation of highly active antiretroviral therapy
13. Zidovudineinduced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion
14. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein
15. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
16. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
17. Latent infection of CD4+ T-cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
18. Identification of a reserovir for HIV-1 in patients on highly active antiretroviral therapy
19. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
20. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon
21. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
22. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects
23. Frequency of class I HLA-restricted anti-HIV CD8+ T-cells in individuals receiving highly active antiretroviral therapy (HAART)
24. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T-cell loss: Evidence supporting a protective role for CTL in vivo
25. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
26. + T-cell depletion in simian immunodeficiency virus-infected macaques
27. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
28. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus type 1 (HIV-1) infection and positive cytotoxic T-lymphocyte response to ALVAC-HIV recombinant canarypox vaccines
29. + lymphocytes respond to different HIV epitopes in seronegative and infected subjects
30. + lymphocyte responses in the cervix of HIV1-resistant prostitutes in Nairobi
31. T-cell epitope mapping by flow cytometry
32. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
33. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
34. Crystalluria and urinary tract abnormalities associated with indinavir
35. + T-cell expansions: Evidence for impaired CTL effector function
36. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
37. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
38. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
39. Visceral abdominal-fat accumulation associated with use of indinavir
40. Lactic acidosis associated with stavudine administration: A report of five cases
41. Human trials of HIV-1 vaccines
42. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
43. Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection
44. Changes in plasma HIV1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS
45. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
46. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
47. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
48. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1infected long-term nonprogressors
49. Role of cellular immunity in protection against HIV infection
50. Cytotoxic T-cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
51. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
52. Indinavir-associated lipodystrophy
53. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy